Sambrinvest — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Santero is a Belgium-based biotech company developing antibacterial drugs, including an RSH inhibitor programme targeting Pseudomonas aeruginosa and multidrug-resistant pathogens.
AI & Machine LearningBiotechDeep TechHealthtechBrussels, BE
Abel Garcia-Pino(Co-founder & Scientific Advisor)inCédric Govaerts(Co-founder & Scientific Advisor)inMark Beards(Chief Executive Officer)inEmilie Racine(COO & Head of Chemistry)inCuong Vuong(Chief Scientific Officer)inValérie Gallien(Chief of Staff)in
Co-investorsNewton Biocapital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.